Apr 10 |
This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?
|
Apr 10 |
Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress
|
Apr 9 |
EVP Research & Development Fady Malik Sells Shares of Cytokinetics Inc (CYTK)
|
Apr 5 |
Cytokinetics releases more data on hypertrophic cardiomyopathy drug aficamten
|
Apr 5 |
Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session
|
Apr 1 |
Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
|
Apr 1 |
Cytokinetics, Incorporated: Buyout Speculation Persists
|
Mar 26 |
Cytokinetics gains amid renewed takeover speculation
|
Mar 25 |
Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual Scientific Session
|
Mar 20 |
2 Incredible Growth Stocks to Buy Right Now
|